
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+2
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeonas investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Companys fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITALTM trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Companys development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeonas novel, next-generation AAV capsids are being evaluated to improve tropism...
Gene therapy,biotechnology,cell therapy,rare disease,epidermolysis bullosa,pediatric rare diseases,and manufacturing
Abeona therapeutics operates in the Biotechnology research industry.
Abeona therapeutics's revenue is 11m - 100m
Abeona therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.